RxDoctor Payments Data

Donna Knight, APRN

Family Medicine · Spartanburg, SCNPI 1184049926

Payments from drug & device makers

$2,289in general payments, 2019–2025

Across 147 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$485
  • AbbVie$443
  • AstraZeneca$420
  • Lilly USA, LLC$326
  • Amgen$228
  • Lucid Diagnostics Inc.$104
  • plus $283 from 9 others

What the payments were for

  • Food & beverage$2,289100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,289 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$569
Medicare patients
22
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol51$56,184
MounjaroTirzepatide16$16,253
Albuterol Sulfate HfaAlbuterol Sulfate50$1,577
Atorvastatin Calcium123$1,086
Gabapentin39$678
Metoprolol Succinate44$617
Fluticasone Propionate33$349
Omeprazole22$311
Buspirone Hcl12$241
Amlodipine Besylate57$225
Tizanidine Hcl23$217
Baclofen13$216
Spironolactone24$214
Pantoprazole Sodium36$195
Lisinopril36$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$420$56,18451 claims
Lilly USA, LLCMounjaro$326$16,25316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →